These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 197737)

  • 1. [Measurement of parathormone (PTH) and cyclic AMP (c AMP) in 50 patients with primary hyperparathyroidism (1st degree HPT)].
    Schmidt-Gayk H; Hüfner M; Haueisen H; Stengel R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1888-90. PubMed ID: 197737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the measurement of nephrogenic cAMP in primary hyperparathyroidism].
    Traba M; Rapado A; de la Piedra C; Castrillo JM; Esbrit P
    Rev Clin Esp; 1982 May; 165(4):251-4. PubMed ID: 6291105
    [No Abstract]   [Full Text] [Related]  

  • 3. [PTH, cyclic AMP and hydroxyproline. Diagnostic importance in hypercalciuria and primary hyperparathyroidism].
    Barceló P; Novillo R; Covarsí A; Brassesco M; Del Rio G
    Acta Med Port; 1983; 4(9-10):399-402. PubMed ID: 6318522
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperparathyoidism: influence of glomerular filtration rate on urinary excretion of cyclic AMP.
    Schmidt-Gayk H; Stengel R; Haueisen H; Hüfner M; Ritz E; Jakobs KH
    Klin Wochenschr; 1977 Mar; 55(6):275-81. PubMed ID: 191682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism.
    Heath H; Purnell DC
    J Lab Clin Med; 1980 Dec; 96(6):974-84. PubMed ID: 6253580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
    Gardin JP; Paillard M
    Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypercalciuria, primary hyperparathyroidism and calcium nephrolithiasis].
    Ivanov I
    Vutr Boles; 1984; 23(2):1-7. PubMed ID: 6331011
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent hyperparathyroidism in renal transplant patients.
    Pabico RC; Ward HN; McKenna BA; Freeman RB
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():68-72. PubMed ID: 226952
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
    Kaplan EL; Fang VS; Sugimoto J; Fredland A
    Surgery; 1982 Nov; 92(5):822-6. PubMed ID: 6291182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone, phosphate and the kidney.
    Kleerekoper M; Bernstein RS; Rao DS; Frame B; Levin NW; Parfitt AM
    Prog Biochem Pharmacol; 1980; 17():190-8. PubMed ID: 6259656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
    Bill G; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1983 Mar; 113(9):327-30. PubMed ID: 6302835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone].
    Louboutin JY; Feuillu A; Allain H; Bernat M; Meadeb J; Pawlotsky Y
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):707-13. PubMed ID: 6256846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary hyperparathyroidism (1st degree HPT): plasma vitamin D and urinary cyclic AMP during the postoperative phase].
    Schmidt-Gayk H; Haueisen H; Martiskainen I; Röher HD
    Langenbecks Arch Chir; 1975; Suppl():481-67. PubMed ID: 1207282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
    Hirschel-Scholz S; Caverzasio J; Bonjour JP
    J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case report: primary hyperparathyroidism--comparison before and after parathyroidectomy by oral calcium tolerance test].
    Sakamoto W; Kawashima H; Nishijima T; Senju M; Kishimoto T; Maekawa M
    Hinyokika Kiyo; 1987 Dec; 33(12):2084-9. PubMed ID: 2834926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorpropamide-induced inhibition of serum calcium, urinary calcium, and cyclic AMP responses to parathyroid hormone.
    Numann PJ; Breslau N; Rao KJ; Coulson R; Moses AM
    Surg Forum; 1975; 26():190-2. PubMed ID: 175514
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.
    Olmer M; Berland Y; Argemi B
    Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH-infusion and estimation of urinary cAMP in hyperparathyroidism.
    von Lilienfeld-Toal H; Hüfner M; Hesch RD
    Acta Endocrinol Suppl (Copenh); 1973; 173():164. PubMed ID: 4353563
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory diagnosis of primary hyperparathyroidism.
    Marcus R
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):647-58. PubMed ID: 2550219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.